Cargando…

David and Goliath - Employer Takes on Health Care Cost Management

Detalles Bibliográficos
Autor principal:	Curtiss, Frederic R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2004
Materias:	Editorial Subjects In This Issue
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438099/ https://www.ncbi.nlm.nih.gov/pubmed/15548130 http://dx.doi.org/10.18553/jmcp.2004.10.6.557

Ejemplares similares

Obscurins: Goliaths and Davids Take over Non-Muscle Tissues
por: Ackermann, Maegen A., et al.
Publicado: (2014)

Heartburn in Consumer-Directed Health Care and the Cost Outcomes of Therapeutic Maximum Allowable Cost
por: Curtiss, Frederic R.
Publicado: (2006)

Finding the Truth About Health Care Cost Drivers - Price Versus Utilization Factors
por: Curtiss, Frederic R.
Publicado: (2003)

Correction: Obscurins: Goliaths and Davids Take over Non-Muscle Tissues
por: Ackermann, Maegen A., et al.
Publicado: (2018)

Contractual Arrangements Between HMOs and Medical Groups to Manage Drug Costs
por: Curtiss, Frederic R.
Publicado: (2003)

Alternate Managed Care Approaches to Disease Management of Allergic Rhinitis
por: Curtiss, Frederic R.
Publicado: (2004)

Value for Money in Disease Management of Acute Coronary Syndrome - The Price of Aspirin to Reduce the Costs of ACS
por: Curtiss, Frederic R.
Publicado: (2005)

Pressure on Pharmacy Benefit Managers for Disclosure and Demonstration of Value - Rebates and Drug Benegit Cost Savings
por: Curtiss, Frederic R.
Publicado: (2003)

Alcohol marketing versus public health: David and Goliath?
por: Madden, Mary, et al.
Publicado: (2021)

David and Goliath: chemical perturbation of eukaryotes by bacteria
por: Ho, Louis K., et al.
Publicado: (2015)

Disease Management, Pay-for-Performance, and Clinical Pharmacist Interventions in Diabetes Care
por: Curtiss, Frederic R.
Publicado: (2003)

Pharmacoeconomics - Determiniation of the Cost-Effectiveness of Helicobacter Pylori Eradication
por: Curtiss, Frederic R.
Publicado: (2003)

Which Triptan? - Opportunity for Same or Better Outcomes at Lower Cost
por: Curtiss, Frederic R.
Publicado: (2004)

Clinical, Service, and Cost Outcomes of Computerized Prescription Order Entry
por: Curtiss, Frederic R.
Publicado: (2005)

Reducing the Risk of Fractures - The Options Narrow for Cost-Effective Therapeutic Alternatives
por: Curtiss, Frederic R.
Publicado: (2004)

Clinical, Service, and Cost Outcomes of Drug Coverage Edits and Quanitity Limits
por: Curtiss, Frederic R.
Publicado: (2003)

Does Member Cost Sharing Pose a Threat to Desirable Patient Outcomes?
por: Curtiss, Frederic R.
Publicado: (2004)

PandT Committees - Black Boxes Versus AMCP Format, and What Is the True Cost and Value of Pimecrolimus
por: Curtiss, Frederic R.
Publicado: (2005)

Effects of Physician Report Cards, Knowledge of Drug Prices, and Financial Incentives in Prescription Drug Costs
por: Curtiss, Frederic R.
Publicado: (2003)

Formulary Management Methods and Pharmacoeconomics
por: Curtiss, Frederic R.
Publicado: (2003)

Disease Management of ADHD and Measures of Compliance
por: Curtiss, Frederic R.
Publicado: (2004)

Value for Money in Disease Management of Benign Prostatic Hyperplasia
por: Curtiss, Frederic R.
Publicado: (2004)

Spending Money to Save Money - Cardiovascular Disease Management
por: Curtiss, Frederic R.
Publicado: (2004)

Evidence-based Medicine, Practice Guidelines, and Disease Management
por: Curtiss, Frederic R.
Publicado: (2003)

Medication Therapy Management Programs - Will Patient Need be Satisfied
por: Curtiss, Frederic R.
Publicado: (2005)

Disease Management Oppurtunities for IBS - Placebo Versus Active Therapy
por: Curtiss, Frederic R.
Publicado: (2004)

The Relative Value of Disease Management Programs Versus Drug Manufacturer Rebates
por: Curtiss, Frederic R.
Publicado: (2003)

Real-World Research in Diabetes Care and Protocols for Patient Privacy
por: Curtiss, Frederic R.
Publicado: (2003)

Clinical Pharmacist Intervention in a Primary Care Medical Group Reduces Financial Losses
por: Curtiss, Frederic R.
Publicado: (2004)

Niacin for phosphate control: A case of David versus Goliath
por: Sampathkumar, K.
Publicado: (2016)

Prescription Drug Expenditures, Financial Burden, and Health Plan Satisfaction Among Medicare Beneficiaries
por: Curtiss, Frederic R.
Publicado: (2003)

David vs. Goliath: The Structure, Function, and Clinical Prospects of Antibody Fragments
por: Bates, Adam, et al.
Publicado: (2019)

Left pulmonary artery sling and COVID-19: David against Goliath
por: Renzulli, Matteo, et al.
Publicado: (2021)

A Challenge to Goliath
por: Rossner, Mike
Publicado: (2009)

A challenge to Goliath
por: Rossner, Mike
Publicado: (2009)

Step-Therapy Edits for PPIs and COX-2 Drugs - What We Do and Do Not Know
por: Curtiss, Frederic R.
Publicado: (2004)

OTC Omeprazole for Your Heartburn - Enormous Value-for-Money Opportunity
por: Curtiss, Frederic R.
Publicado: (2004)

Drug Formulary Decisions - Evaluating the Risks and Benefits of Hormone Replacement Therapy
por: Curtiss, Frederic R.
Publicado: (2004)

3-Tier Drug Benefit Designs Based on Sound Drug Formulary Principles Will Maximize Favorable Outcomes
por: Curtiss, Frederic R.
Publicado: (2004)

Who Needs Another Clinical Practice Guideline?
por: Curtiss, Frederic R.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_abjo4neptstbaemj0t805v2gln